Masaaki Sekine

1.1k total citations
27 papers, 428 citations indexed

About

Masaaki Sekine is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Masaaki Sekine has authored 27 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Genetics. Recurrent topics in Masaaki Sekine's work include T-cell and Retrovirus Studies (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Vector-Borne Animal Diseases (5 papers). Masaaki Sekine is often cited by papers focused on T-cell and Retrovirus Studies (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Vector-Borne Animal Diseases (5 papers). Masaaki Sekine collaborates with scholars based in Japan and United States. Masaaki Sekine's co-authors include Noriko Ando, A. Yasuda, F. Formanek, Kazuya Shimoda, Tomonori Hidaka, Kotaro Shide, Takuro Kameda, Yoko Kubuki, Ayako Kamiunten and Haruko Shimoda and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Masaaki Sekine

26 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Sekine Japan 10 154 128 92 66 46 27 428
A. Holmes United Kingdom 7 143 0.9× 36 0.3× 111 1.2× 32 0.5× 10 0.2× 17 396
Matteo Allegretti Italy 12 423 2.7× 25 0.2× 75 0.8× 15 0.2× 5 0.1× 27 616
Kate Hsu Taiwan 13 226 1.5× 15 0.1× 91 1.0× 42 0.6× 5 0.1× 44 594
Juraj Kokavec Slovakia 11 304 2.0× 43 0.3× 48 0.5× 34 0.5× 5 0.1× 39 485
Joseph Khoory United States 8 117 0.8× 22 0.2× 33 0.4× 31 0.5× 4 0.1× 14 418
Teddy Huang Taiwan 6 86 0.6× 29 0.2× 17 0.2× 17 0.3× 4 0.1× 26 248
Souzan Armstrong Canada 13 212 1.4× 30 0.2× 42 0.5× 14 0.2× 8 0.2× 14 494
T. France Canada 5 53 0.3× 31 0.2× 22 0.2× 14 0.2× 38 0.8× 6 339
Dean Bottino United States 13 188 1.2× 14 0.1× 40 0.4× 35 0.5× 4 0.1× 31 625
David J. Kane United States 10 290 1.9× 11 0.1× 72 0.8× 21 0.3× 19 0.4× 18 552

Countries citing papers authored by Masaaki Sekine

Since Specialization
Citations

This map shows the geographic impact of Masaaki Sekine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Sekine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Sekine more than expected).

Fields of papers citing papers by Masaaki Sekine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Sekine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Sekine. The network helps show where Masaaki Sekine may publish in the future.

Co-authorship network of co-authors of Masaaki Sekine

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Sekine. A scholar is included among the top collaborators of Masaaki Sekine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Sekine. Masaaki Sekine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshimitsu, Makoto, Ilseung Choi, Shigeru Kusumoto, et al.. (2025). A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma. Blood. 146(12). 1440–1449. 5 indexed citations
2.
Yoshikawa, Naoki, Masaaki Sekine, Keiichi Akizuki, et al.. (2021). Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion. Pharmaceuticals. 14(4). 353–353. 6 indexed citations
3.
Shide, Kotaro, Takuro Kameda, Ayako Kamiunten, et al.. (2020). Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms. Blood. 136(1). 106–118. 10 indexed citations
4.
Kameda, Takuro, Kotaro Shide, Ayako Kamiunten, et al.. (2020). CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ. Blood. 136(Supplement 1). 17–18. 2 indexed citations
5.
Akizuki, Keiichi, Masaaki Sekine, Yasunori Kogure, et al.. (2020). TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia. BMC Cancer. 20(1). 5–5. 17 indexed citations
6.
Shide, Kotaro, Takuro Kameda, Ayako Kamiunten, et al.. (2020). Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice. Leukemia. 35(2). 454–467. 29 indexed citations
7.
Shide, Kotaro, Takuro Kameda, Masaaki Sekine, et al.. (2017). Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm. Anticancer Research. 37(7). 3841–3847. 1 indexed citations
8.
Sekine, Masaaki, Yoko Kubuki, Takuro Kameda, et al.. (2017). Effects of mogamulizumab in adult T‐cell leukemia/lymphoma in clinical practice. European Journal Of Haematology. 98(5). 501–507. 17 indexed citations
9.
Sekine, Masaaki, Masaki Takeuchi, Seiichi Sato, et al.. (2016). Mogamulizumab for ATLL in Clinical Practice. Blood. 128(22). 2998–2998. 1 indexed citations
10.
Kameda, Takuro, Kotaro Shide, Ayako Kamiunten, et al.. (2015). Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms. Genomics Data. 4. 102–108. 3 indexed citations
11.
Shimoda, Kazuya, Kotaro Shide, Takuro Kameda, et al.. (2015). TET2 Mutation in Adult T-Cell Leukemia/Lymphoma. Journal of Clinical and Experimental Hematopathology. 55(3). 145–149. 16 indexed citations
12.
Shide, Kotaro, Takuro Kameda, Haruko Shimoda, et al.. (2012). TET2 is essential for survival and hematopoietic stem cell homeostasis. Leukemia. 26(10). 2216–2223. 64 indexed citations
13.
Kameda, Takuro, Kotaro Shide, Haruko Shimoda, et al.. (2010). Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma. International Journal of Hematology. 92(2). 320–325. 10 indexed citations
14.
Formanek, F., et al.. (2010). Terahertz imaging applied to cancer diagnosis. Physics in Medicine and Biology. 55(16). 4615–4623. 144 indexed citations
15.
Tanaka, Akihiko, et al.. (2001). Triglyceride-Rich Lipoprotein Cholesterol Exceeds Low-Density Lipoprotein Cholesterol in Hypertriglyceridemia Patients. Hormone and Metabolic Research. 33(10). 612–617. 1 indexed citations
16.
Ai, Masumi, Akira Tanaka, Keiko Ogita, et al.. (2000). Relationship between Hyperinsulinemia and Remnant Lipoprotein Concentrations in Patients with Impaired Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism. 85(10). 3557–3560. 20 indexed citations
17.
Kakuta, Tsunekazu, et al.. (1988). A case of pemphigus vulgaris with thymoma.. Nihon Naika Gakkai Zasshi. 77(1). 22–25. 2 indexed citations
18.
Ohta, Takahiro, Kentaro Shimokado, Masaaki Sekine, et al.. (1986). BIOCHEMICAL STUDIES ON ALCOHOL INDUCED CORONARY SPASMS : Coronary Spasm : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY. Japanese Circulation Journal-english Edition. 50(8). 744–745. 2 indexed citations
19.
Yajima, Michiyoshi, et al.. (1985). Plasma thromboxane B2, 6-KETO PGF1.ALPHA. and cyclic nucleotides levels as related to treadmill exercise test in patients with ischemic heart disease.. Japanese Circulation Journal. 49(1). 38–45. 6 indexed citations
20.
Sekine, Masaaki, et al.. (1957). 337) Experimental Study on Vapour Permeability through Materials (Part 2)(Scientefic Basis of Planning Building). Transactions of the Architectural Institute of Japan. 57.2(0). 145–148.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026